Rosalind Advisors, Inc. - 31 Dec 2025 SCHEDULE 13G/A Report for FENNEC PHARMACEUTICALS INC. Common Shares (FENC)

Filing Manager
Rosalind Advisors, Inc.
Reporting Manager
Rosalind Advisors, Inc.
Security
FENNEC PHARMACEUTICALS INC. Common Shares
Symbol
FENC
Shares outstanding
28,028,980 shares
Disclosed Ownership
2,746,840 shares
Ownership
9.8%
Form type
SCHEDULE 13G/A
Filing time
11 Feb 2026, 13:58:32 UTC
Date of event
31 Dec 2025
Previous filing
13 Nov 2025
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Rosalind Advisors, Inc. 9.8% 2,746,840 2,746,840 Steven Salamon President
SALAMON STEVEN A J 9.5% 2,680,174 66,666 2,613,508 Steven Salamon Steven Salamon
Aharon Gil 9.5% 2,680,174 66,666 2,613,508 Aharon Gil Aharon Gil
Rosalind Master Fund L.P. 9.3% 2,613,508 2,613,508 Mike McDonald Director, Rosalind (Cayman) Ltd. (as General Partner to Rosalind Master Fund)